Stock 2E40 PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus PHAXIAM Therapeutics S.A. Deutsche Boerse AG

Equities

2E40

FR001400K4B1

Delayed Deutsche Boerse AG
Other stock markets
 03:15:12 2024-07-01 EDT 		5-day change 1st Jan Change
1.95 EUR +3.17% Intraday chart for PHAXIAM Therapeutics S.A. -1.02% -56.18%
06-28 Would you like some more inflation? Our Logo
06-28 Phaxiam: fewer funds raised than expected CF

Evolution of the average Target Price on PHAXIAM Therapeutics S.A.

Price target over the last 5 years

History of analyst recommendation changes

9707.4xkBrfJ3ZtPap2Kiaa5ZGUYe_Ne53ofXIBLszKdcCI4.pGt4_MQeS5ut4gqWE_4XTwVate7Sh7CeFV6zu8ApUcyraUXPhgMp_orTOw~2a04c1b0a61569c22a7dfbb9c9e456a0

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.99 EUR
Average target price
5.1 EUR
Spread / Average Target
+156.28%
High Price Target
5.3 EUR
Spread / Highest target
+166.33%
Low Price Target
4.9 EUR
Spread / Lowest Target
+146.23%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. 2E40 Stock
  5. Consensus PHAXIAM Therapeutics S.A.